Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Status:
Recruiting
Trial end date:
2023-07-31
Target enrollment:
Participant gender:
Summary
The study team will examine the effects of FDA approved stimulant and non-stimulant
medications for ADHD, among youth with ADHD and with and without Oppositional Defiant
Disorder (ODD) or Conduct Disorder (CD), on reward systems of the brain using fMRI.
Phase:
Phase 4
Details
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Collaborator:
National Institute on Drug Abuse (NIDA)
Treatments:
Atomoxetine Hydrochloride Central Nervous System Stimulants Methylphenidate